Description

Denosumab Injection is a monoclonal antibody used to treat osteoporosis in postmenopausal women and prevent bone fractures in patients receiving certain cancer treatments. It inhibits RANKL, reducing bone resorption, improving bone density, and lowering the risk of skeletal-related events.